Top Markets
Coin of the day
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940
Classifica tra le azioni #519
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Prezzo delle azioni
$1,071.12
Capitalizzazione di mercato
$49.58B
Variazione (1 giorno)
-3.73%
Variazione (1 anno)
-5.56%
Paese
KR
Scambia Samsung Biologics Co.,Ltd. (207940)

Categoria

Storico del prezzo dell'azione per Samsung Biologics Co.,Ltd. (207940)
Prezzo di chiusura più alto: $1.09K il 2026-08-01

Prezzo di chiusura più basso: $215.60 il 2016-11-01
Storico del prezzo dell'azione di Samsung Biologics Co.,Ltd. dal 2016 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -3.69%
2025 12.74%
2024 21.95%
2023 -14.64%
2022 -16.07%
2021 2.83%
2020 117.47%
2019 6.18%
2018 -1.56%
2017 164.22%
2016 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$97.64 -44.67%
AU